Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Is Pfizer Stock a Buy in 2024?
08:00am, Sunday, 14'th Jan 2024
Pfizer's shares badly underperformed the broader market in 2023. Still, the drugmaker may be worth adding to your portfolio this year for two clear-cut reasons.
Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends
06:15am, Sunday, 14'th Jan 2024
If you're a growth investor, an article about overlooked high-yield dividend stocks is not for you. However, with the recent numbers showing that inflation is that dinner party guest that is overstayi
7 Incredible Reasons to Buy Pfizer Stock Right Now
10:00am, Saturday, 13'th Jan 2024
Pfizer accomplished an impressive feat last year, despite its poor stock market performance. The drugmaker's successes should allow it to perform much better over the long run.
2 Red Flags That Could Sink Pfizer in 2024
05:05am, Saturday, 13'th Jan 2024
Though there are reasons to like Pfizer's long-term prospects, the near term may continue to be challenging. Pfizer's CEO recently expressed disappointment in the company's -- and the stock's -- 2023
Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort
01:46pm, Friday, 12'th Jan 2024
Pfizer Inc. stock has been on a protracted, yearlong decline due to stronger-than-expected normalization in COVID product uptake rates in 2023. But management's conservative 2024 guidance for COVID pr
Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation
03:05pm, Thursday, 11'th Jan 2024
For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the “Dividend Dynasty.” Here, seven high-yield stocks stand as pillars of long-term wealth ac
Pfizer's 2024 Outlook: Is PFE Stock Poised for a Major Rebound?
09:15am, Thursday, 11'th Jan 2024
Post-pandemic, the global bio-pharmaceutical sector, often overlooked, presents undervalued opportunities, notably in blue-chip stocks like Pfizer (NYSE: PFE ). Following a 42% correction in the past
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
01:17pm, Wednesday, 10'th Jan 2024
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
08:01am, Wednesday, 10'th Jan 2024
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025
08:34pm, Tuesday, 09'th Jan 2024
Today, identifying investments with promising growth potential is a quest every investor undertakes. Within the loud noises of the stock market, three standout companies are making waves.
Here's Why Pfizer (PFE) Fell More Than Broader Market
06:47pm, Tuesday, 09'th Jan 2024
Pfizer (PFE) closed the most recent trading day at $29.40, moving -0.61% from the previous trading session.
Trade Tracker: Josh Brown buys Pfizer
12:42pm, Tuesday, 09'th Jan 2024
Josh Brown, CEO at Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to discuss his latest healthcare trade.
Is Pfizer Stock a Buy Now?
07:01am, Tuesday, 09'th Jan 2024
Pfizer made tens of billions of dollars on the pandemic, but that business dried up fast. A blockbuster acquisition of Seagen is a long-term opportunity.
Will Pfizer's Stock Bounce Back in 2024?
05:35am, Tuesday, 09'th Jan 2024
Pfizer stock trades at a low multiple of its estimated future earnings. The company's COVID-19-related revenue declined sharply in recent quarters.
Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
08:45pm, Monday, 08'th Jan 2024
Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
